Sun Pharmaceutical Industries Limited

Sun House, Plot No. 201 B/1,

Western Express Highway, Goregaon (E),

Mumbai - 400 063, Maharashtra, INDIA.

Tel. : (91-22) 4324 4324

Fax : (91-22) 4324 4343

Website: www.sunpharma.com

CIN: L24230GJ1993PLC019050

January 25, 2022

National Stock Exchange of India Limited,

BSE Limited,

Exchange Plaza, 5th Floor,

Market Operations Dept.

Plot No. C/1, G Block,

P. J. Towers,

Bandra Kurla Complex,

Dalal Street,

Bandra (East), Mumbai- 400 051

Mumbai - 400 001

Scrip Symbol: SUNPHARMA

Scrip Code: 524715

Dear Sir/Madam,

Sub: Prior intimation under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

This is to inform you that the Board of Directors of the Company, at its meeting scheduled to be held on Monday, January 31, 2022, will inter-alia consider declaration of Interim Dividend on the equity shares of the Company, for the financial year 2021-22.

This is for your information and dissemination.

Thanking you,

Yours faithfully,

For Sun Pharmaceutical Industries Limited

(Ashok Bhuta)

Compliance Officer

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Sun Pharmaceutical Industries Ltd. published this content on 25 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 January 2022 09:06:05 UTC.